A detailed history of Ra Capital Management, L.P. transactions in Nkarta, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 10,805,129 shares of NKTX stock, worth $61.7 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
10,805,129
Holding current value
$61.7 Million
% of portfolio
0.96%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.27 - $10.82 $56.9 Million - $117 Million
10,805,129 New
10,805,129 $63.9 Million
Q1 2024

May 15, 2024

BUY
$5.59 - $15.71 $16.8 Million - $47.1 Million
3,000,000 Added 38.44%
10,805,129 $117 Million
Q4 2023

Feb 14, 2024

BUY
$1.31 - $6.6 $10.2 Million - $51.5 Million
7,805,129 New
7,805,129 $51.5 Million
Q2 2022

Aug 15, 2022

BUY
$7.77 - $19.44 $17.1 Million - $42.8 Million
2,200,000 Added 39.25%
7,805,129 $96.2 Million
Q3 2020

Nov 16, 2020

BUY
$23.52 - $47.9 $132 Million - $268 Million
5,605,129 New
5,605,129 $168 Million

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $278M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Ra Capital Management, L.P. Portfolio

Follow Ra Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.